Teleflex Incorporated (TFX) stock forecast · P/E 2083, rev $569.0M
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
This TFX forecast page states what the cached financials imply — not a price target and not a guarantee. Teleflex Incorporated outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported TFX revenue for 2025-12-31 was $569.0M. Net income was -$714.3M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Period-over-period revenue change is not in cache for TFX, so this page does not invent a growth rate.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next TFX 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the TFX stock page.
Not investment advice.